Baxter launches swine flu vaccine

Celvapan should be used in accordance with official guidance. The dose recommendations are based on safety and immunogenicity data available from the administration of a vaccine containing 7.5 microgram HA derived from A/Vietnam/1203/2004 (H₅N₁) in adults, including the elderly. Doses were given on days 0 and 21.

The decision to use Celvapan in each age group should take into account the extent of the clinical data available with the version containing H₅N₁ antigen and the disease characteristics of the current influenza pandemic.

View Celvapan drug record

Further information: Baxter

To sign up for the MIMS monthly news update, register at www.mims.co.uk/bulletins.